Insulet (PODD) Current Deferred Tax Assets (2011 - 2012)
Insulet's (PODD) quarterly Current Deferred Tax Assets came in at $500000.0 in Q4 2012, down 44.44% YoY from $900000.0 in Q1 2012, and down 44.44% on a QoQ basis from $900000.0 in Q3 2012.
Insulet (PODD) Current Deferred Tax Assets (2011 - 2012) Analysis & Trends
Insulet (PODD) has 2 years of Current Deferred Tax Assets data on file, last reported at $500000.0 in Q4 2012.
- Quarterly Current Deferred Tax Assets fell 44.44% year-over-year to $500000.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $500000.0 (down 44.44% YoY) and the FY2012 annual result came in at $500000.0, down 44.44% from the prior year.
- Current Deferred Tax Assets fell to $500000.0 in Q4 2012, from $900000.0 in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $900000.0 in Q4 2011 to a low of $500000.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Insulet | 10.34 Bn | 9.80 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 500,000.00 |
| Dec 31, 2012 | 500,000.00 |
| Sep 30, 2012 | 900,000.00 |
| Sep 30, 2012 | 900,000.00 |
| Jun 30, 2012 | 900,000.00 |
| Jun 30, 2012 | 900,000.00 |
| Mar 31, 2012 | 900,000.00 |
| Mar 31, 2012 | 900,000.00 |
| Dec 31, 2011 | 900,000.00 |
| Dec 31, 2011 | 900,000.00 |